Systemic anti cancer therapy (SACT) clinical management guidelines for bone and soft tissue sarcoma

Date: 
1 Apr 2017
Source: 
Northern Ireland Cancer Network
Audience: 
Patients and public
Professionals
Type of resource: 
Guidance

Systemic anti-cancer therapy (SACT) is a key treatment in managing sarcoma. Its role is often in conjunction with local treatment (surgery and/or radiotherapy) so the decision points for proceeding with different treatment options are included. These guidelines describe the agreed management for patients with soft tissue sarcoma, bone sarcoma and fibromatosis. (GIST will be covered in the upper GI SACT policy.)